To print: Select File and then Print from your browser's menu
August 28, 2009
Recent weeks have brought word about several diabetes products that are scheduled to be discontinued within the next year.
Eli Lilly and Company has decided to stop producing Humulin 50/50, a premixed insulin consisting of 50% NPH suspension and 50% Regular insulin. Based on its current supply, Eli Lilly anticipates that the insulin, which is used by roughly 3,000 people nationwide, will be available in pharmacies through the end of April 2010. (This does not affect the availability of Humalog 50/50 insulin.)
Additionally, Novo Nordisk will be discontinuing Novolin InnoLet disposable insulin pens and Novolin PenFill 3-milliliter insulin cartridges. The final date of sale for the Novolin R InnoLet, Novolin N InnoLet, Novolin 70/30 InnoLet, Novolin R PenFill 3-milliliter cartridges, Novolin N 3-milliliter cartridges, and NovoLin 70/30 PenFill 3-milliliter cartridges is December 31, 2009.
For more information about the discontinuation of Humulin 50/50 insulin, see the information sheet issued by Eli Lilly. And to learn more about the discontinuation of Novolin InnoLet pens and Novolin PenFill 3-milliliter insulin cartridges, read the information sheet supplied by Novo Nordisk.
Disclaimer of Medical Advice:You understand that the blogs posts and comments to such blog posts (whether posted by us, our agents, bloggers, or by users) do not constitute medical advice or recommendation of any kind and you should not rely on any information contained on such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.